In an age-matched comparison of patients with ALK-negative vs. ALK-positive ALCL, there was no difference in failure-free survival or OS when considering either the group of patients aged 40 years or those aged < 40 years(Savage et al., 2008). This evidence concerns the gene ALK and anaplastic large cell lymphoma.